Ozempic threatens profits at food and beverage makers worldwide spokesman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spokesman.com Daily Mail and Mail on Sunday newspapers.
Bristol-Myers Squibb Co. agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion Sunday, a price that disappointed investors after reported interest from rival Sanofi.
Bristol-Myers Leapfrogs Sanofi to Buy Cancer Drug-Maker Mirati for $4 8 Billion bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.